(Q44351275)

English

Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis (English)

1 reference

Europe PubMed Central

2 December 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

author name string

Koh LP

1

1 reference

Europe PubMed Central

2 December 2017

Hwang WY

2

1 reference

Europe PubMed Central

2 December 2017

Chuah CT

3

1 reference

Europe PubMed Central

2 December 2017

Linn YC

4

1 reference

Europe PubMed Central

2 December 2017

Goh YT

5

1 reference

Europe PubMed Central

2 December 2017

Tan CH

6

1 reference

Europe PubMed Central

2 December 2017

Ng HJ

7

1 reference

Europe PubMed Central

2 December 2017

Tan PH

8

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

2 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

2 December 2017

31

1 reference

Europe PubMed Central

2 December 2017

4

1 reference

Europe PubMed Central

2 December 2017

305-308

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703836

0 references

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

21 January 2018

Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-myeloablative transplants for malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703836

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703836

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44351275&oldid=2109650552"